Agenda

All times displayed for Europe/Madrid timezone.

Conference

An Introduction to Biopharmaceutical Processing – making the transition from small to large molecules
08:30 - 10:00 bioLIVE Insights Theatre
Breakfast Briefing

The Breakfast Briefing is free to attend but seats are very limited. To secure your seat, please register here: https://www.bio.live/breakfast-briefing-2

Keynote Presentation I Growth Opportunities in the Biopharmaceutical Industry
10:30 - 11:00 bioLIVE Content Dome
Global Growth in Biomanufacturing
Interview I Trends in the Supply and Demand for Mammalian Cell Culture Capacity
11:00 - 11:30 bioLIVE Content Dome
Global Growth in Biomanufacturing
Panel Discussion | Growth Perspectives in the US and Europe
11:30 - 12:30 bioLIVE Content Dome
Global Growth in Biomanufacturing
The Importance of Gelatine and its Endotoxin Level for Applications in Regenerative Medicine
12:30 - 13:30 bioLIVE Content Dome
Lunch Briefing

Sponsored by:

The Lunch Briefing is free to attend but seats are very limited. To secure your seat, please register here: www.bio.live/lunch-briefing-1

Presentation I The Cell and Gene Therapy Market Opportunity for CMO’s
14:15 - 14:30 bioLIVE Content Dome
Cell & Gene Therapies
Presentation I Development and Innovation to adress Cell and Gene Therapy MFG and Commercialization Challenges
14:30 - 15:00 bioLIVE Content Dome
Cell & Gene Therapies
Presentation I Development of Oral Live Bio-therapeutic Products
15:00 - 15:30 bioLIVE Content Dome
Cell & Gene Therapies

Sponsored by:

Panel Discussion
15:30 - 17:00 bioLIVE Content Dome
Cell & Gene Therapies

This discussion about cell and gene therapy manufacturing will provide an industry insight on regulatory considerations and opportunities for growth paving the way to commercialization.

bioLIVE Insight Briefing

Introduction to Luina Bio
10:30 - 11:00 bioLIVE Insights Theatre
Insight Briefing

The presentation describes the services that Luina Bio offers in the field of biomanufacturing and how we can help our customer achieve their development and production milestones faster and more effectively

Introduction of an innovative vaccine against Hand, Foot and Mouth Disease
11:00 - 11:30 bioLIVE Insights Theatre
Insight Briefing

Sponsored by:

MANUFACTURING OF ADCs: CHALLENGES IN SCALING UP DS and DP PROCESS FROM CLINICAL TO COMMERCIAL
11:30 - 12:00 bioLIVE Insights Theatre
Insight Briefing

Sponsored by:

The speech will be initially focused in presenting and explaining some of the challenges we faced as a CDMO to handle manufacturing of ADCs and managing the criticalities of this class of therapeutics.
Second part of the speech is a business case related to our experience in supporting scaling up of ADCs, from early clinic stage up to BLA with a focus on process characterization and robustness to ensure consistency of process integrity

MJ BIOTECH – CDMO services with focus on Quality Cost Delivery
12:00 - 12:30 bioLIVE Insights Theatre
Insight Briefing
BIOTECHPHARMA UAB
12:30 - 13:00 bioLIVE Insights Theatre
Insight Briefing

Sponsored by:

By attending this session, participants who have monoclonal antibodies or recombinant proteins in their clinical pipeline will gain insight how Biotechpharma as a full-service CDMO (Contract Development and Manufacturing Organisation) can support their development programs with all required services from cell line construction up to GMP-manufacturing. The presentation is also of interest for companies which are looking for a flexible partner for commercial GMP-productions.

An Overview of BioProduction by Sekisui
13:00 - 13:30 bioLIVE Insights Theatre
Insight Briefing

Sponsored by:

RebelBio
13:30 - 14:00 bioLIVE Insights Theatre
Insight Briefing
"See"ing Catalysis - Qzyme Workbench: Design strategies to expand new applications of old enzymes
13:30 - 14:00 bioLIVE Insights Theatre
Insight Briefing

Sponsored by:

Big Pharma Innovation
14:00 - 14:30 bioLIVE Insights Theatre
Insight Briefing
China Chamber
14:00 - 15:00 bioLIVE Insights Theatre
Insight Briefing
EnzBond - A new era in Biocatalysis
15:00 - 15:30 bioLIVE Insights Theatre
Insight Briefing

Sponsored by:

EnzBond spun-out of Oxford University in 2016 and following this has revolutionised the biocatalysis sector with its propriety technology. EnzBond has demonstrated its technology across 8 different reaction classes and has decreased the development time from a year to only few months. Please come learn more about EnzBond and our biocatalysis revolution.

|
15:30 - 16:00 bioLIVE Insights Theatre
Insight Briefing
|
16:00 - 16:30 bioLIVE Insights Theatre
Insight Briefing